Clinical Characteristics and Outcomes of COVID-19 Acute Respiratory Distress Syndrome (ARDS) Survivors in Early Pandemic: A Single Healthcare System Retrospective Study
- PMID: 35971346
- PMCID: PMC9372924
- DOI: 10.7759/cureus.26801
Clinical Characteristics and Outcomes of COVID-19 Acute Respiratory Distress Syndrome (ARDS) Survivors in Early Pandemic: A Single Healthcare System Retrospective Study
Abstract
Introduction: Acute respiratory distress syndrome (ARDS) management in the intensive care unit (ICU) has attracted strong interest since the start of the COVID-19 pandemic. Our retrospective study aims to describe the outcomes and predictors of mortality of ARDS associated with COVID-19 within one university-based healthcare system.
Methods: We identified 165 patients within our healthcare system during the months of April 2020 through July 2020, who were admitted to our medical ICUs and eligible for our study. Baseline patient characteristics, ICU and hospital course information, ICU interventions, ventilator settings, and hospital complications were collected and analyzed using descriptive statistical techniques.
Results: Our cohort had an average age of 64. No significant difference in mortality was identified with male vs. female gender or BMI. Most of the patient cohort was identified as black (68.2%). The overall mortality of our cohort was 38.2%. Hyperlipidemia, coronary artery disease, and chronic obstructive pulmonary disease were all associated with higher mortality. There was a significant difference in mortality between those with higher observed ventilator plateau pressures at 24 hours and higher driving pressures at 24 hours.
Conclusion: COVID-19-associated ARDS is associated with significant mortality. Physicians should be aware of pre-existing conditions potentially related to worse outcomes so that they receive an appropriate level of care in a timely manner. Ventilator management should focus on maintaining low intra-thoracic pressure changes. Prospective studies are needed to guide COVID-19-associated ARDS management.
Keywords: acute respiratory distress syndrome [ards]; covid 19; covid-19 respiratory failure; critical care outcomes; invasive mechanical ventilation.
Copyright © 2022, Vahdatpour et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.Intensive Care Med. 2021 Jan;47(1):60-73. doi: 10.1007/s00134-020-06294-x. Epub 2020 Oct 29. Intensive Care Med. 2021. PMID: 33211135 Free PMC article.
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.Trials. 2021 Mar 1;22(1):172. doi: 10.1186/s13063-021-05116-9. Trials. 2021. PMID: 33648568 Free PMC article.
-
Pressure-controlled versus volume-controlled ventilation for acute respiratory failure due to acute lung injury (ALI) or acute respiratory distress syndrome (ARDS).Cochrane Database Syst Rev. 2015 Jan 14;1(1):CD008807. doi: 10.1002/14651858.CD008807.pub2. Cochrane Database Syst Rev. 2015. PMID: 25586462 Free PMC article. Review.
-
COVID-19-associated acute respiratory distress syndrome versus classical acute respiratory distress syndrome (a narrative review).Iran J Microbiol. 2021 Dec;13(6):737-747. doi: 10.18502/ijm.v13i6.8072. Iran J Microbiol. 2021. PMID: 35222850 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Miscellaneous